Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UT-15C sustained-release tablets in pulmonary arterial hypertension
2009-009366-13Phase 3Completed
- Sponsor
- United Therapeutics Corporation
- Start
- Aug 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pulmonary arterial hypertension (PAH) comparing Treprostinil diethanolamine sustained-release tablets with Placebo (2 arms). Primary endpoint: Change in 6-minute walk distance from baseline to Week 16. Started Aug 2009; status: completed.
02
Drugs
treprostinil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2009-009366-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009366-13.